Becoming a Cardiothoracic Surgeon: An Emerging Profile in the Surgery Theater and through Scientific Publications
Author and Curator: Aviva Lev-Ari, PhD, RN

Article ID #65: Becoming a Cardiothoracic Surgeon: An Emerging Profile in the Surgery Theater and through Scientific Publications. Published on 7/8/2013
WordCloud Image Produced by Adam Tubman
Two components of an Emerging Profile of a Young Cardiothoracic Surgeon were researched by the Author for the case of Dr. Isaac George, Assistant Professor of Surgery, Division of Cardiothoracic Surgery, Department of Surgery, New York Presbyterian Hospital/Columbia University Medical Center , New York, NY.
The two components being:
1. the Cardiothoracic Surgery Theater
2. the Scientific Publications
I noted with interest Dr. George’s second publication, to be about a very well known surgeon in the US and Europe, John Benjamin Murphy. written by Dr. George and two other colleagues, George I, Hardy MA, Widmann WD. published in Curr Surg. 2004 Sep-Oct;61(5):439-41.
Dr. Murphy, is best remembered for the eponymous clinical sign that is used in evaluating patients with acute cholecystitis. His career spanned general surgery, orthopedics, neurosurgery, and cardiothoracic surgery, which helped him to gain international prominence in the surgical profession. Mayo Clinic co-founder William James Mayo called him “the surgical genius of our generation.”
http://en.wikipedia.org/wiki/John_Benjamin_Murphy
[Musana, Kenneth and Steven H. Yale (May 2005). “John Benjamin Murphy (1857–1916)”. Clinical Medicine & Research. Retrieved 2008-05-16.]
I assume that Dr. Murphy’s contributions to Thoracic surgery were of interest to Dr. George to inspire him to write on the subject and elect that Specialty in Surgery.
Murphy was first in the U.S. to induce (1898) artificial immobilization and collapse of the lung in treatment of pulmonary tuberculosis. He was a pioneer in the use of bone grafting and made contributions to the understanding and management of ankylosis as well as independently proposing artificial pneumothorax to manage unilateral lung disease in tuberculosis.
-
-
- «It is the purpose of every man’s life to do something worthy of the recognition and appreciation of his fellow men. . . . By their superior intellectual qualifications, their fidelity to purpose and above all their indefatigable labour the few become leaders.»
-
Journal of the American Medical Association, Chicago, 1911, 57: 1.
SOURCE Whonamedit? A dictionary of medical eponyms, John Benjamin Murphy
I came across Dr. Isaac George’s name while researching clinical indications for Inhaled Nitric Oxide in June 2013, upon the recent publication of Leaders in Pharmaceutical Business Intelligence FIRST e-Book on Amazon (Biomed e-Books) [Kindle Edition]
Perspectives on Nitric Oxide in Disease Mechanisms
http://www.amazon.com/dp/B00DINFFYC
Dr. George’s article on Outcomes After Inhaled Nitric Oxide Therapy was particularly useful in my own research on the topic,
Being myself in Analytics and quantitative model design, 1976-2004, I found of particular interest the range of quantitative methodologies used in the following article by Isaac George, assuming that his days at MIT, came very handy in 2006:
George, Isaac, Xydas, Steve, Topkara, Veli K., Ferdinando, Corrina, Barnwell, Eileen C., Gableman, Larissa, Sladen, Robert N., Naka, Yoshifumi, Oz, Mehmet C.
Clinical Indication for Use and Outcomes After Inhaled Nitric Oxide Therapy
Ann Thorac Surg 2006 82: 2161-2169
As a result of studying this article, I became aware that it has impacted favorably my 6/2013, Editorial decision, for a forthcoming book on Cardiovascular Disease in 2013. The Editorial decision regarding the selection and representation of prominent Cardiothoracic Surgery Theater in the US, and my personal decision to select a Young Cardiothoracic Surgeon
Dr. Isaac George, Assistant Professor of Surgery, Division of Cardiothoracic Surgery, Department of Surgery, New York Presbyterian Hospital/Columbia University Medical Center, New York, NY
Education Profile and Medical Training of a Cardiac Surgeon
![]() |
|
SOURCE http://asp.cpmc.columbia.edu/facdb/profile_list.asp?uni=ig2006&DepAffil=Surgery
The decision to focus on Cardiothoracic Surgery @Presbeterian as described in Dr. Isaac George’s research had yielded one Sub-Chapter (4.1) in Chapter 4
Cardiac Surgery, Cardiothoracic Surgical Procedures and Percutaneous Coronary Intervention (PCI)/Coronary Angioplasty – Heart and Cardiovascular Medical Devices in Use in Operating Rooms and in Catheterization Labs in the US
in Volume Three in a forthcoming three volume Series of e-Books on Cardiovascular Diseases
Cardiovascular Diseases: Causes, Risks and Management
This very Sub-Chapter represents milestones in Dr. Isaac George – Becoming a Cardiothoracic Surgeon: An Emerging Profile through Scientific Publications, This profile is now in:
Volume Three
Management of Cardiovascular Diseases
Justin D. Pearlman MD ME PhD MA FACC, Editor
Leaders in Pharmaceutical Business Intelligence, Los Angeles
Editor-in-Chief BioMed E-Book Series
Leaders in Pharmaceutical Business Intelligence, Boston
avivalev-ari@alum.berkeley.edu
Chapter 5
Invasive Procedures by Surgery versus Catheterization
5.1 Cardiothoracic Surgery
Aviva Lev-Ari, PhD, RN
5.2: Catheter Interventions
Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
5.3: Transcatheter (Percutaneous) Valves
Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
5.4: Transcatheter (Percutaneous) Pumps
Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
5.4.2 Phrenic Nerve Stimulation in Patients with Cheyne-Stokes Respiration and Congestive Heart Failure
Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
Content Analysis of Surgeon Isaac George, MD – Publications on PubMed
SOURCE
Original classification by Aviva Lev-Ari, PhD, RN, 7/8/2013
Title |
Journal |
Year |
CABG |
Valves material |
End stage HF AMI shock |
Congen |
Animal Model |
Heart & |
Stent exteriorization |
CCI |
13 |
X |
|||||
Left Main Coronary |
CCI |
13 |
X |
|||||
TAVR-MVR |
JACC |
13 |
X |
|||||
Paravalvular |
CVI |
13 |
X |
|||||
Cardiogenic Shock |
Heart-Lung |
12 |
X |
|||||
Cheyne-Stokes |
Chest |
12 |
X |
|||||
Myostatin |
PlusOne |
11 |
X |
|||||
Aortic Root & RV |
ATS |
11 |
X |
|||||
Beta-Adrenergic |
CV Research |
11 |
X |
|||||
Erythropoietin LV Systolic |
J CV Pharmacol |
10 |
X |
|||||
Myostatin & HF |
Eur J Heart Failure |
10 |
X |
|||||
Stentless in valve conduit |
ATS |
09 |
X |
|||||
BNP peptide- infusion-post MI |
Am J Physiol- Heart Circ Physiology |
09 |
X |
|||||
Marginal donor heart |
ATS |
09 |
X |
|||||
Device-surface & Immunogenic |
J Thoracic CV Surg |
08 |
X |
|||||
Myocardial electromagnetic |
J Cell Physiol |
08 |
X |
|||||
Clenbuterol- muscle-mass |
J Heart- Lung Transplant |
08 |
X |
|||||
Bradycardic LV |
J Pharmacol Exper Therap |
07 |
X |
|||||
Ischemia- post Heart Transplant |
J Thoracic CV Surgery |
07 |
X |
|||||
Octogen CABG |
ATS |
07 |
X |
|||||
Ventricular synchrony |
Eup J Cardio-thoracic Surg |
07 |
X |
|||||
Inhaled NO |
ATS |
06 |
X |
X |
||||
Adult heart-donor- to-pediatric |
J Thoracic CV Surg |
06 |
X |
|||||
Clenbuterol on LVAD |
J Heart-Lung Transplant |
06 |
X |
|||||
LV-CA stent |
Heart Surg Forum |
06 |
X |
|||||
LVAD myocarditis |
J Thoracic CV Surg |
06 |
X |
|||||
MI-Ischemia |
Am J Physiol- Ht-Circ Physiol |
06 |
X |
It is the unique combination of Animal Model Research, Biomaterial, Surgical Procedures and Molecular Cardiology, N=33.
Cardiothoracic Surgeon: An Emerging Profile in the Surgery Theater
Isaac George, MD – Clinical Specialties
- Adult aortic and mitral valve surgery
- Transcatheter aortic and mitral valve implantation
- Hybrid coronary artery bypass surgery
- Complex aortic surgery
- Complex valvular surgery
- Heart failure and transplant surgery
- Reoperative cardiac surgery
- Thoracic aortic endograft implantation
VIDEOS on CardioThoracic Surgery @ Department of Cardiothoracic Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City
VIEW VIDEO on the new Heart Center @ Presbyterian Hospital
http://videos.nyp.org/videos/introduction-to-the-vivian-and-seymour-milstein-family-heart-center
VIEW VIDEO on the two Hybrid OR with Siemens Artis Zeego Technology
http://videos.nyp.org/videos/tour-a-hybrid-or-with-siemens-artis-zeego-technology
VIEW VIDEO on Mininally Invesive and Conventional Therapy for Aortic Dissection and Aneurysms – Hybrid Surgery Case
VIEW VIDEO on Mitral Valve Repair and Replacement – Dr. Karl H. Krieger
Dr. Karl H. Krieger, the Vice Chairman of the Department of Cardiothoracic Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City, discusses treatment for Mitral Valve Disease. Specifically, Dr. Krieger compares the options of Mitral Valve Repair with Mitral Valve Replacement.
This video with Dr. Krieger is from a web cast at the Ronald O. Perelman Heart Institute at NewYork-Presbyterian.
VIEW VIDEO on Left Ventricular Assist Devices (LVADs) – Dr. Jonathan Chen
Dr. Jonathan Chen, the Site Chief for Pediatric Cardiac Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City, explains how Left Ventricular Assist Devices (LVADs) work and how they can benefit patients with heart failure.
LVADs are implantable devices that help the heart pump blood. They can be used as a temporary therapy, allowing patients’ hearts to rest while they recover from cardiac events such as heart attacks, or while they wait for hearts to become available for transplants. For some patients whose hearts are unlikely to recover and are not candidates for heart transplants, the devices may be used as a permanent therapy. Heart failure, especially in severe forms, can force patients to lead restricted lives because often even very limited physical activity, such as walking from one room to another, will leave them breathless.
Dr. Chen is a pediatric cardiothoracic surgeon, yet the information in the video is applicable to adult patients as well.
VIEW VIDEO on Transcatheter Aortic Valve Implantation @ Presbyterian Hospital
http://videos.nyp.org/videos/chapter-3-transcatheter-aortic-valve-implantation
Heart, Heart-Lung Transplantation @ Presbyterian Hospital
Organ transplantation that prolongs and dramatically improves quality of life is nearly a daily occurrence at Columbia University Medical Center.
The success of solid organ transplantation – with improved surgical techniques, replacement organ procurement, and medical management – is advancing each year. Many of these advances have resulted from scientific and clinical research conducted at Columbia University Medical Center.
A Brief History of Transplantation at Columbia
Transplantation: Where we’ve been, where we’re going

When he transplanted a chimpanzee kidney into a human patient in the late 1960’s, the late Keith Reemtsma, MD, then Department of Surgery Chairman at Tulane University, revolutionized treatment of end-stage organ failure and initiated an era of unprecedented exploration into organ transplantation that would affect the lives of patients around the world.
Transferring to Columbia-Presbyterian Medical Center in 1971, Dr. Reemtsma recruited Mark A. Hardy, MD, who laid another cornerstone of organ transplant medicine by founding the program for dialysis and kidney transplantation. Dr. Hardy based the new program on the principle of collaborative clinical care between surgeons and nephrologists. During a time when renal transplant programs were managed by one or the other discipline but never by both simultaneously, the medical community regarded the concept as folly. Yet the program grew steadily, as did the program’s immune tolerance research initiatives to induce the transplant recipient’s body to accept a donor organ. This multidisciplinary cooperation also led to major contributions in immunogenetics, immunosuppression, and treatment of autoimmune diseases and lymphoma — and it ultimately became the overarching principle for all the NewYork-Presbyterian Hospital transplant services.
Colleagues universally give credit to Eric A. Rose, MD, who co-founded the heart transplantation program with Dr. Reemtsma, for his successful transformation of the program into the outstanding center it is today. A parade of achievements marks the history of the heart transplant program, including the first mechanical bridge-totransplantation using intra-aortic balloon pumps in the 1970’s, and the first successful pediatric heart transplant, performed by Dr. Rose in 1984. Under the guidance of Dr. Rose and his successors, the program has pioneered research in immunosuppressant medications, mechanical assist devices, and minimally invasive surgical procedures. It currently performs over 100 heart transplants yearly, with among the highest success rates in the nation.
Also in 2004, Lloyd E. Ratner, MD, succeeded Dr. Hardy as director of the renal and pancreas transplant program. One of the first to perform laparoscopic donor operations, Dr. Ratner has found creative solutions to overcome immune barriers to kidney transplantation. The program now routinely uses extended-criteria donor organs, performs transplants among incompatible donors, and is a leader in coordinating “donor swaps” to maximize availability of compatible donor organs. Since Dr. Ratner’s arrival, Columbia has been designated one of ten regional islet resource centers in the U.S. that isolate and transplant pancreatic cells to treat type 1 diabetes as part of a limited protocol controlled by the FDA. Recent progress in visualization of pancreatic islets using PET technology, under the guidance of Paul Harris, PhD, has been recognized by the scientific community as a milestone in this developing field.
NYPH/Columbia received UNOS approval for pancreatic transplantation in January 2008. Our premier kidney transplant program is facilitating rapid growth of the new pancreatic transplantation program, which overlaps both in its patient population and its surgical and medical expertise. The northeast region of the U.S. has been consistently underserved as far as access to pancreatic transplantation, with relatively few centers serving a disproportionately large metropolitan population. The expanding program at NewYork-Presbyterian now provides much-needed access to patients with end-stage pancreatic disease in New York state, particularly those with the most complex medical and surgical challenges.
Transplantation of cells, rather than organs, is emerging as a therapy with enormous potential. Transplantation of either a patient’s own or a foreign donor’s bone marrow cells, for example, offers hope of regenerating the heart so that patients with heart failure may be able to avoid heart transplantation.
In introducing the transplantation programs, it would be remiss to neglect mention of the yet another dimension in which they excel — education. Physician training is a top priority, and NYPH/Columbia has trained many of the greatest transplant surgeons over the last 20 years, including many of the leaders of transplant programs throughout the U.S.
http://columbiasurgery.org/transplant/history.html
Transplant Initiative
At NewYork-Presbyterian Hospital/Columbia University Medical Center, the Transplant Initiative (TI) has been launched to drive the growth of both clinical and research aspects of transplantation. This multi-year undertaking will involve Departments of Medicine, Pathology, Pediatrics, and Surgery and all of the solid organ transplantation programs, both adult and pediatrics. It is led by its Executive Director, Jean C. Emond, MD.
Although NYP/Columbia is already a national leader in clinical transplantation with respect to volume and patient outcomes, this initiative will further leverage the diverse expertise of its transplant scientists and clinicians.
Heart Transplantation
Approximately 2,200 heart transplants are now performed each year in more than 150 heart transplant centers in the United States. The surgeons and cardiologists of Columbia University Medical Center of NYPH have a long and distinguished history of advancing “standards of care” and the survival rates of our patients by using innovative surgical techniques, by applying our basic scientific research in immunosuppression to the clinical setting, and by inventing and perfecting life-sustaining cardiac assist devices that prolong life while waiting for organ availability.
Lung and Heart-Lung Transplantation
Columbia University Medical Center’s lung and heart-lung transplantation program, which began in 1985, is fast approaching its 200th transplant. Performing more than 30 transplants each year, the lung and heart-lung transplant teams have earned a national reputation for excellence. Our world-renowned transplantation researchers have helped lead the way to improvements in care that, nationwide, have increased the long-term survival rate for lung transplantation by 50% over the past seven years. Among those improvements are new immunosuppressive agents, new antibiotics, refined surgical techniques, and a more comprehensive understanding of follow-up care.
http://columbiasurgery.org/transplant/
It is the combination of basic research at the molecular cardiology level, biomaterial, surgical procedures and PUBLICATION of Cases and research results that found me in Dr. George’s territory as a renewed inspiration.
For Author’s training & experience @ MGH – Cardiac Floor – Ellison 11, BWH – CCU, Tower 3 – 12Fl, BIDMC – Acute Surgery, Farr 9, and Texas Heart Institute, Perfusion, Faulkner Hospital – ICU
http://pharmaceuticalintelligence.com/founder/scientific-and-medical-affairs-chronological-cv/
and in Part II, Section IV in
Surgeon Isaac George, MD – Training in the OR @ Presbyterian Hospital
2011-2012 | Interventional Cardiology/Hybrid Cardiac Surgery Fellowship | |
New York Presbyterian Hospital – Columbia University Medical Center, New York, NY | ||
2011 | Ventricular Assist Device/Cardiac Transplant Fellowship, Minimally Invasive, Cardiac Surgery | |
New York Presbyterian Hospital – Columbia University Medical Center, New York, NY | ||
2009-2011 | Fellow, Cardiothoracic Surgery | |
New York Presbyterian Hospital – Columbia University Medical Center, New York, NY | ||
2008-2009 | Post-Doctoral Clinical Fellow, Cardiothoracic Surgery | |
New York Presbyterian Hospital – Columbia University Medical Center, New York, NY | ||
2006-2008 | Resident, General Surgery | |
New York Presbyterian Hospital – Columbia University Medical Center, New York, NY | ||
2004-2006 | Research Fellow, Cardiothoracic Surgery | |
New York Presbyterian Hospital – Columbia University Medical Center, New York, NY | ||
2002-2004 | Resident, General Surgery | |
New York Presbyterian Hospital – Columbia University Medical Center, New York, NY | ||
2001-2002 | Internship, General Surgery | |
New York Presbyterian Hospital – Columbia University Medical Center, New York, NY |
SOURCE
http://asp.cpmc.columbia.edu/facdb/profile_list.asp?uni=ig2006&DepAffil=Surgery
Surgeon Isaac George, MD – Publications on PubMed
http://www.ncbi.nlm.nih.gov/pubmed
Select item 234757651.
Stent exteriorization facilitates surgical repair for large-bore sheath complications.
George I, Shrikhande G, Williams MR.
Catheter Cardiovasc Interv. 2013 Mar 8. doi: 10.1002/ccd.24918. [Epub ahead of print]
- PMID:
23475765
[PubMed – as supplied by publisher]
Paradis JM, George I, Kodali S.
Catheter Cardiovasc Interv. 2013 Feb 14. doi: 10.1002/ccd.24865. [Epub ahead of print]
- PMID:
23413172
[PubMed – as supplied by publisher]
Paradis JM, Kodali SK, Hahn RT, George I, Daneault B, Koss E, Nazif TM, Leon MB, Williams MR.
JACC Cardiovasc Interv. 2013 Jan;6(1):94-6. doi: 10.1016/j.jcin.2012.07.018. No abstract available.
- PMID:
23347868
[PubMed – in process]
Daneault B, Koss E, Hahn RT, Kodali S, Williams MR, Généreux P, Paradis JM, George I, Reiss GR, Moses JW, Smith CR, Leon MB.
Circ Cardiovasc Interv. 2013 Feb;6(1):85-91. doi: 10.1161/CIRCINTERVENTIONS.112.971614. Epub 2013 Jan 22.
- PMID:
23339841
[PubMed – in process]
A stepwise progression in the treatment of cardiogenic shock.
Pollack A, Uriel N, George I, Kodali S, Takayama H, Naka Y, Jorde U.
Heart Lung. 2012 Sep-Oct;41(5):500-4. doi: 10.1016/j.hrtlng.2012.03.007. Epub 2012 May 16.
- PMID:
22608034
[PubMed – indexed for MEDLINE]
Zhang XL, Ding N, Wang H, Augostini R, Yang B, Xu D, Ju W, Hou X, Li X, Ni B, Cao K, George I, Wang J, Zhang SJ.
Chest. 2012 Oct;142(4):927-34.
- PMID:
22302299
[PubMed – in process]
Myostatin is elevated in congenital heart disease and after mechanical unloading.
Bish LT, George I, Maybaum S, Yang J, Chen JM, Sweeney HL.
PLoS One. 2011;6(9):e23818. doi: 10.1371/journal.pone.0023818. Epub 2011 Sep 13.
Russo MJ, Easterwood R, Williams MR, George I, Stewart AS.
Ann Thorac Surg. 2011 Jun;91(6):e87-9. doi: 10.1016/j.athoracsur.2011.01.035.
- PMID:
21619955
[PubMed – indexed for MEDLINE]
George I, Sabbah HN, Xu K, Wang N, Wang J.
Cardiovasc Res. 2011 Aug 1;91(3):447-55. doi: 10.1093/cvr/cvr106. Epub 2011 Apr 14.
Xu K, George I, Klotz S, Hay I, Xydas S, Zhang G, Cerami A, Wang J.
J Cardiovasc Pharmacol. 2010 Nov;56(5):506-12. doi: 10.1097/FJC.0b013e3181f4f05a.
- PMID:
20881614
[PubMed – indexed for MEDLINE]
Myostatin activation in patients with advanced heart failure and after mechanical unloading.
George I, Bish LT, Kamalakkannan G, Petrilli CM, Oz MC, Naka Y, Sweeney HL, Maybaum S.
Eur J Heart Fail. 2010 May;12(5):444-53. doi: 10.1093/eurjhf/hfq039. Epub 2010 Mar 27.
Stentless bioprosthesis in a valved conduit: implications for pulmonary reconstruction.
George I, Shah JN, Bacchetta M, Stewart A.
Ann Thorac Surg. 2009 Dec;88(6):2022-4. doi: 10.1016/j.athoracsur.2009.04.145.
- PMID:
19932287
[PubMed – indexed for MEDLINE]
George I, Xydas S, Klotz S, Hay I, Ng C, Chang J, Xu K, Li Z, Protter AA, Wu EX, Oz MC, Wang J.
J Cardiovasc Pharmacol. 2010 Jan;55(1):14-20. doi: 10.1097/FJC.0b013e3181c5e743.
George I, Morrow B, Xu K, Yi GH, Holmes J, Wu EX, Li Z, Protter AA, Oz MC, Wang J.
Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H708-17. doi: 10.1152/ajpheart.00661.2008. Epub 2009 Jun 12.
Matching high-risk recipients with marginal donor hearts is a clinically effective strategy.
Russo MJ, Davies RR, Hong KN, Chen JM, Argenziano M, Moskowitz A, Ascheim DD, George I, Stewart AS, Williams M, Gelijns A, Naka Y.
Ann Thorac Surg. 2009 Apr;87(4):1066-70; discussion 1071. doi: 10.1016/j.athoracsur.2008.12.020.
George I, Colley P, Russo MJ, Martens TP, Burke E, Oz MC, Deng MC, Mancini DM, Naka Y.
J Thorac Cardiovasc Surg. 2008 Jun;135(6):1372-9. doi: 10.1016/j.jtcvs.2007.11.049.
- PMID:
18544389
[PubMed – indexed for MEDLINE]
Myocardial function improved by electromagnetic field induction of stress protein hsp70.
George I, Geddis MS, Lill Z, Lin H, Gomez T, Blank M, Oz MC, Goodman R.
J Cell Physiol. 2008 Sep;216(3):816-23. doi: 10.1002/jcp.21461.
Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure.
Kamalakkannan G, Petrilli CM, George I, LaManca J, McLaughlin BT, Shane E, Mancini DM, Maybaum S.
J Heart Lung Transplant. 2008 Apr;27(4):457-61. doi: 10.1016/j.healun.2008.01.013.
- PMID:
18374884
[PubMed – indexed for MEDLINE]
Cheng Y, George I, Yi GH, Reiken S, Gu A, Tao YK, Muraskin J, Qin S, He KL, Hay I, Yu K, Oz MC, Burkhoff D, Holmes J, Wang J.
J Pharmacol Exp Ther. 2007 May;321(2):469-76. Epub 2007 Feb 2.
Russo MJ, Chen JM, Sorabella RA, Martens TP, Garrido M, Davies RR, George I, Cheema FH, Mosca RS, Mital S, Ascheim DD, Argenziano M, Stewart AS, Oz MC, Naka Y.
J Thorac Cardiovasc Surg. 2007 Feb;133(2):554-9.
- PMID:
17258599
[PubMed – indexed for MEDLINE]
Bardakci H, Cheema FH, Topkara VK, Dang NC, Martens TP, Mercando ML, Forster CS, Benson AA, George I, Russo MJ, Oz MC, Esrig BC.
Ann Thorac Surg. 2007 Feb;83(2):483-9.
- PMID:
17257973
[PubMed – indexed for MEDLINE]
Clinical indication for use and outcomes after inhaled nitric oxide therapy.
George I, Xydas S, Topkara VK, Ferdinando C, Barnwell EC, Gableman L, Sladen RN, Naka Y, Oz MC.
Ann Thorac Surg. 2006 Dec;82(6):2161-9.
- PMID:
17126129
[PubMed – indexed for MEDLINE]
Effect of passive cardiac containment on ventricular synchrony and cardiac function in awake dogs.
George I, Cheng Y, Yi GH, He KL, Li X, Oz MC, Holmes J, Wang J.
Eur J Cardiothorac Surg. 2007 Jan;31(1):55-64. Epub 2006 Nov 1.
- PMID:
17081764
[PubMed – indexed for MEDLINE]
Ray optics model for triangular hollow silicon waveguides.
Isaac G, Khalil D.
Appl Opt. 2006 Oct 10;45(29):7567-78.
- PMID:
17068588
[PubMed]
Russo MJ, Davies RR, Sorabella RA, Martens TP, George I, Cheema FH, Mital S, Mosca RS, Chen JM.
J Thorac Cardiovasc Surg. 2006 Nov;132(5):1208-12.
- PMID:
17059945
[PubMed – indexed for MEDLINE]
George I, Xydas S, Mancini DM, Lamanca J, DiTullio M, Marboe CC, Shane E, Schulman AR, Colley PM, Petrilli CM, Naka Y, Oz MC, Maybaum S.
J Heart Lung Transplant. 2006 Sep;25(9):1084-90.
- PMID:
16962470
[PubMed – indexed for MEDLINE]
Atta K, Forlenza N, Gujski M, Hashmi S, Isaac G.
Psychiatry (Edgmont). 2006 Sep;3(9):56-61.
Yi GH, George I, He KL, Lee MJ, Cahalan P, Zhang G, Gu A, Klotz S, Burkhoff D, Wang J.
Heart Surg Forum. 2006;9(5):E744-9.
- PMID:
16809127
[PubMed – indexed for MEDLINE]
Ventricular assist device use for the treatment of acute viral myocarditis.
Topkara VK, Dang NC, Barili F, Martens TP, George I, Cheema FH, Bardakci H, Ozcan AV, Naka Y.
J Thorac Cardiovasc Surg. 2006 May;131(5):1190-1. No abstract available.
- PMID:
16678619
[PubMed – indexed for MEDLINE]
George I, Yi GH, Schulman AR, Morrow BT, Cheng Y, Gu A, Zhang G, Oz MC, Burkhoff D, Wang J.
Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1126-37. Epub 2006 Apr 14.
Topkara VK, Dang NC, Barili F, Cheema FH, Martens TP, George I, Bardakci H, Oz MC, Naka Y.
J Heart Lung Transplant. 2006 Apr;25(4):404-8. Epub 2006 Feb 28.
- PMID:
16563969
[PubMed – indexed for MEDLINE]
George I, Hardy MA, Widmann WD.
Curr Surg. 2004 Sep-Oct;61(5):439-41. No abstract available.
- PMID:
15475090
[PubMed – indexed for MEDLINE]
Bissonnette LR, Roy G, Poutier L, Cober SG, Isaac GA.
Appl Opt. 2002 Oct 20;41(30):6307-24.
- PMID:
12396180
[PubMed]
Bardakci H, Cheema FH, Topkara VK, Dang NC, Martens TP, Mercando ML, Forster CS, Benson AA, George I, Russo MJ, Oz MC, Esrig BC.
Ann Thorac Surg. 2007 Feb;83(2):483-9.
- PMID:
17257973
[PubMed – indexed for MEDLINE]
Clinical indication for use and outcomes after inhaled nitric oxide therapy.
George I, Xydas S, Topkara VK, Ferdinando C, Barnwell EC, Gableman L, Sladen RN, Naka Y, Oz MC.
Ann Thorac Surg. 2006 Dec;82(6):2161-9.
- PMID:
17126129
[PubMed – indexed for MEDLINE]
Effect of passive cardiac containment on ventricular synchrony and cardiac function in awake dogs.
George I, Cheng Y, Yi GH, He KL, Li X, Oz MC, Holmes J, Wang J.
Eur J Cardiothorac Surg. 2007 Jan;31(1):55-64. Epub 2006 Nov 1.
- PMID:
17081764
[PubMed – indexed for MEDLINE]
Ray optics model for triangular hollow silicon waveguides.
Isaac G, Khalil D.
Appl Opt. 2006 Oct 10;45(29):7567-78.
- PMID:
17068588
[PubMed]
Russo MJ, Davies RR, Sorabella RA, Martens TP, George I, Cheema FH, Mital S, Mosca RS, Chen JM.
J Thorac Cardiovasc Surg. 2006 Nov;132(5):1208-12.
- PMID:
17059945
[PubMed – indexed for MEDLINE]
George I, Xydas S, Mancini DM, Lamanca J, DiTullio M, Marboe CC, Shane E, Schulman AR, Colley PM, Petrilli CM, Naka Y, Oz MC, Maybaum S.
J Heart Lung Transplant. 2006 Sep;25(9):1084-90.
- PMID:
16962470
[PubMed – indexed for MEDLINE]
Atta K, Forlenza N, Gujski M, Hashmi S, Isaac G.
Psychiatry (Edgmont). 2006 Sep;3(9):56-61.
Yi GH, George I, He KL, Lee MJ, Cahalan P, Zhang G, Gu A, Klotz S, Burkhoff D, Wang J.
Heart Surg Forum. 2006;9(5):E744-9.
- PMID:
16809127
[PubMed – indexed for MEDLINE]
Ventricular assist device use for the treatment of acute viral myocarditis.
Topkara VK, Dang NC, Barili F, Martens TP, George I, Cheema FH, Bardakci H, Ozcan AV, Naka Y.
J Thorac Cardiovasc Surg. 2006 May;131(5):1190-1. No abstract available.
- PMID:
16678619
[PubMed – indexed for MEDLINE]
George I, Yi GH, Schulman AR, Morrow BT, Cheng Y, Gu A, Zhang G, Oz MC, Burkhoff D, Wang J.
Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1126-37. Epub 2006 Apr 14.
Topkara VK, Dang NC, Barili F, Cheema FH, Martens TP, George I, Bardakci H, Oz MC, Naka Y.
J Heart Lung Transplant. 2006 Apr;25(4):404-8. Epub 2006 Feb 28.
- PMID:
16563969
[PubMed – indexed for MEDLINE]
George I, Hardy MA, Widmann WD.
Curr Surg. 2004 Sep-Oct;61(5):439-41. No abstract available.
- PMID:
15475090
[PubMed – indexed for MEDLINE]
Bissonnette LR, Roy G, Poutier L, Cober SG, Isaac GA.
Appl Opt. 2002 Oct 20;41(30):6307-24.
- PMID:
12396180
[PubMed]
I actually consider this amazing blog , âSAME SCIENTIFIC IMPACT: Scientific Publishing –
Open Journals vs. Subscription-based « Pharmaceutical Intelligenceâ, very compelling plus the blog post ended up being a good read.
Many thanks,Annette
I actually consider this amazing blog , âSAME SCIENTIFIC IMPACT: Scientific Publishing –
Open Journals vs. Subscription-based « Pharmaceutical Intelligenceâ, very compelling plus the blog post ended up being a good read.
Many thanks,Annette